Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:DJ
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:TS-19
|
| gptkbp:clinical_trial |
ongoing for vaccine efficacy
|
| gptkbp:data_usage |
higher than previous variants
|
| gptkbp:descendant |
gptkb:XBB_lineage
|
| gptkbp:discovered_by |
gptkb:2023
|
| gptkbp:distribution |
global
|
| gptkbp:genetic_diversity |
important for tracking mutations
multiple spike protein mutations |
| gptkbp:healthcare |
increased surveillance
|
| https://www.w3.org/2000/01/rdf-schema#label |
Omicron XBB.1.16
|
| gptkbp:is_recognized_by |
gptkb:India
|
| gptkbp:is_vulnerable_to |
reduced against infection
may evade some immune responses |
| gptkbp:origin |
evolution from previous variants
|
| gptkbp:public_awareness |
increased media coverage
|
| gptkbp:research_focus |
vaccine adaptation
|
| gptkbp:risk_factor |
higher risk for unvaccinated individuals
|
| gptkbp:scientific_classification |
Variant of Interest
|
| gptkbp:side_effect |
increased hospitalizations
|
| gptkbp:sire |
boosters recommended for vulnerable populations
|
| gptkbp:symptoms |
similar to other Omicron variants
|
| gptkbp:treatment |
similar to other COVID-19 treatments
|
| gptkbp:variant |
gptkb:Omicron
|